STUDY ON THE CONTROL OF PAIN SYNTOMS AND SIDE EFFECTS THOUGH THE USE OF PHARMACOLOGY ASSOSATION OF OXICODONE/NALOXONE IN MODERATE TO SEVERE POST OPERATIVE PAI

Phase 1

• Conditions: POSTOPERATIVE PAIN AFTER HYSTERECTOMY; MedDRA version: 20.1 Level: LLT Classification code 10054711 Term: Postoperative pain System Organ Class: 100000004863; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2014-005521-12-IT
• Lead Sponsor: FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-18
• Last Update Posted: 30 April 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 141

Inclusion Criteria

FEMALE; AGE >18; HYSTERECTOMY
Are the trial subjects under 18? no
Number of subjects for this age range: 1
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 141
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

AGE < 18; ASA>3; OPPIOIDE ALLERGY; HOME TERAPY WITH ANALGESIC; CRONIC PAIN

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified